Users with existing oral health conditions If you already have gum disease, active cavities, or other oral health conditions before starting a GLP-1 medication, address these issues first
Total sniffing time also showed a significant smell x treatment interaction (F(1, 22)= 4.881, p = 0.0379), with the semaglutide-treated group spending significantly less time sniffing urine, representing a 33.9% reduction (Semaglutide: 22.18 seconds, Control: 33.6 seconds
the hair follicle can grow and survive, the excess of DHT (dihydrotestosteron) is neutralised and the blood circulation is stimulated
2024;47(Suppl 1)
"As use of this medication is extended and expanded for weight loss and other health advocacy, there is an opportunity to do much more, including product development, packaging, online and in-store merchandising, education, and promotion." Opportunities include: Merchandise dietary and nutritional support items near the pharmacy in drug and grocery, improving the shopping experience for consumers taking GLP-1s Understand that 91% of Millennials, 90% of Gen Z, and 64% of Gen X on GLP-1 medications are interested in packaged foods that support their weight loss goals, and they want messaging called out on the package Meet consumers where they are with product and health information, amplifying digital commerce programming Advance opportunities on retailer apps and websites to support these shoppers Acosta Group's "GLP-1 & The Weight Loss Revolution Shopper Insights Study" was conducted Feb
